iblog
European Digital Identity Wallet: On the cusp of a European digital identity
During the last Observatory Conference, the proposal for the creation of a European Digital Identity Wallet was presented.
Assilea: Data management to prepare for the future
Success Stories as told by our partners
Fulmine Group: The QES linking recipient and sender
Success Stories: Experiences in the Digital Sphere told by Businesses Themselves
So You Want to Be a B Corp: Here’s the Whys and Wherefores
Intesa has set out on the road to B Corp status. How does one become a B Corp? What benefits does this certification carry with it? Find out in this article.
At CCB Group, Customer Connectedness Survives and Thrives in the Digital Age
Success Stories: Experiences in the Digital Sphere told by Businesses Themselves
Self Sovereign Identity: the Regulatory Environment
The “Self Sovereign Identity” (SSI) digital-identity model may provide a lasting solution to the often spurtive and indiscriminate sharing of our personal information. How might this innovation become incorporated into Italian and European regulations?
Sara Assicurazioni: Loyalty Ensured Thanks to Electronic Signatures
Success Stories: Experiences in the Digital Sphere told by Businesses Themselves.
FCA Bank: Loans go Digital
Success Stories: Experiences in the Digital Sphere told by Businesses Themselves.
Sorgenia: Going Paperless, and Accelerating the Time to Market
Success Stories: Experiences in the Digital Sphere told by Businesses Themselves
Exponential Sustainability
Intesa is one of the first tech companies in Europe to take a B Lab B Impact Assessment (BIA). What role will technology and digital services play in tackling the major challenges of the 21st century?
Pitagora – Customer Experience Goes Digital Thanks to Video Interaction and DTM
Success Stories: Companies Relate their Experiences in the Digital Transformation.
IN2DAFNE: Innovation that Helps Patients
The project is born out of a concrete demand within the pharma supply chain to provide a hi-tech solution to tackle the problem of limited-supply and out-of-stock medicine.